LICN
Lichen International Limited
There isn't enough reported data to score LICN yet.
RKLB
Rocket Lab USA, Inc.
RKLB lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
LICN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Strong |
LICN's balance sheet is currently strong, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
LICN PE Valuation
LICN has no meaningful PE right now: it lost money over the past year.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
LICN Forward outlook
There aren't enough analyst estimates for LICN to show an outlook.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
LICN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2025 | -$73.25 | -222% |
| Q4 2024 | -$34.79 | -154% |
LICN and RKLB do not have enough comparable growth data to identify a winner.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
LICN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $10.3M | -28% |
| Q4 2025 | $10.3M | -56% |
| Q2 2025 | $14.3M | -21% |
| Q4 2024 | $23.4M | -1.9% |
| Q2 2024 | $18.1M | +14% |
| Q4 2023 | $23.8M | +35% |
| Q2 2023 | $15.9M | -1.4% |
| Q4 2022 | $17.7M | +2% |
LICN's revenue has slid since its 2023 peak: $10M last quarter, down 43% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -85% | -94 points |
| Q4 2025 | -89% | -129 points |
| Q2 2025 | -37% | -55 points |
| Q4 2024 | -27% | -54 points |
| Q2 2024 | 9.4% | -26 points |
| Q4 2023 | 39% | +13 points |
| Q2 2023 | 18% | -21 points |
| Q4 2022 | 28% | -2.8 points |
LICN's operating margin was −85% last quarter, down 94 points from the same quarter a year ago, near the bottom of its range since 2014.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over LICN in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB has the edge over LICN on profitability, with a higher operating margin.
LICN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2023 | -$1.7M | -146% |
| Q2 2023 | -$956K | -119% |
| Q4 2022 | $3.7M | -1.4% |
| Q2 2022 | $5.2M | +45% |
| Q4 2021 | $3.7M | -31% |
| Q2 2021 | $3.6M | +21% |
| Q4 2020 | $5.4M | +295% |
| Q2 2020 | $2.9M | +114% |
LICN's free cash flow has turned negative after years in the green: −$19M over the past year.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
LICN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +10881% | +16.2M shares |
| 3 years | -27% | -6.2M shares |
| 5 years | -43% | -12.4M shares |
LICN has 16M diluted shares, up 10881% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q4 2025 | — |
| Q4 2022 | — |
| Q2 2022 | — |
| Q4 2021 | — |
| Q2 2021 | — |
| Q4 2020 | — |
| Q2 2020 | — |
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has the edge over LICN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
LICN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | -1.6x | Net Cash |
LICN has more cash than debt.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LICN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.7 | Neutral |
| Stochastic | 1.5 | Oversold |
LICN's weekly RSI is 34 (neutral) and its Stochastic is 2 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
LICN PE vs Industrials Sector
| Metric | LICN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
LICN has no meaningful PE right now: it lost money over the past year.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
LICN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.75 | 95% below |
| 20 week MA | $1.03 | 96% below |
| 50 week MA | $2.48 | 98% below |
| 100 week MA | $5.66 | 99% below |
RKLB has stronger trend alignment. LICN is above 0 of 4 weekly averages versus RKLB above 3 of 5.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
LICN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $820.0 | $396.0 | -52% |
| 2024 | $396.0 | $46.4 | -88% |
| 2025 | $46.4 | $2.97 | -94% |
| 2026 YTD | $2.97 | $0.04 | -99% |
LICN has finished every year since 2023 lower, and it's down 99% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over LICN on returns for 2026, with the stronger performance.